학술논문
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
Document Type
Article
Author
Bertoglio, F.; Fühner, V.; Ruschig, M.; Heine, P.A.; Meier, D.; Langreder, N.; Steinke, S.; Ballmann, R.; Schneider, K.-T.; Roth, K.D.R.; Riese, P.; Schäckermann, D.; Korn, J.; Koch, A.; Becker, M.; Scholz, M.; Moreira, G.M.S.G.; Wenzel, E.V.; Russo, G.; Dübel, S.; Schubert, M.; Hust, M.; Abassi, L.; Rand, U.; Chaudhry, M.Z.; Eschke, K.; Kim, Y.; Čičin-Šain, L.; Klünemann, T.; Van den Heuvel, J.; Kuhn, P.; Schirrmann, T.; Frenzel, A.; Zock-Emmenthal, S.; Garritsen, H.S.P.; Casu, S.; Gerstner, A.; Roth, G.; Adler, J.; Trimpert, J.; Hermann, A.
Source
In: Cell Reports . (Cell Reports, 27 July 2021, 36(4))
Subject
Language
English
ISSN
22111247